Amanote Research
Register
Sign In
Current Evidence for the Use of Platelet Gpiib/Iiia Receptor Inhibitors in Acute Coronary Syndromes
The Internet Journal of Anesthesiology
doi 10.5580/264a
Full Text
Open PDF
Abstract
Available in
full text
Date
January 1, 1999
Authors
Unknown
Publisher
Internet Scientific Publishers, LLC
Related search
Current Role of Platelet Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes
JAMA - Journal of the American Medical Association
Medicine
Routine Upstream Initiation vs Deferred Selective Use of Glycoprotein IIb/IIIa Inhibitors in Acute Coronary Syndromes
JAMA - Journal of the American Medical Association
Medicine
Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment Elevation Acute Coronary Syndromes
ACC Current Journal Review
RGD-independent Binding of Russell’s Viper Venom Kunitz-Type Protease Inhibitors to Platelet GPIIb/IIIa Receptor
Scientific Reports
Multidisciplinary
Cost-Effectiveness of Platelet Glycoprotein IIb/IIIa Inhibition With Eptifibatide in Patients With Non-St-Elevation Acute Coronary Syndromes
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Increased Platelet Binding to Circulating Monocytes in Acute Coronary Syndromes
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Kistrin, a Polypeptide Platelet GPIIb/IIIa Receptor Antagonist, Enhances and Sustains Coronary Arterial Thrombolysis With Recombinant Tissue-Type Plasminogen Activator in a Canine Preparation
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Clonal Restriction of Platelet-Associated Anti-GPIIb/IIIa Autoantibodies in Patients With Chronic ITP
Thrombosis and Haemostasis
Hematology
Biogenesis of the Platelet Receptor for Fibrinogen: Evidence for Separate Precursors for Glycoproteins IIb and IIIa.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
